Covaxin, a vaccine for COVID-19, will be available in the first quarter of next year, said Suchitra Ella, joint managing director of Bharat Biotech on Wednesday.
"With safety and efficacy data, Covaxin will be available in the first quarter of next year to the categories and the first responders according to the plan that government of India is embarking upon for phased vaccination," Ms Ella said.
A team of foreign heads of missions in India had visited leading biotech companies in Hyderabad involved in COVID-19 vaccine development.
The Indian arm of US pharmaceutical giant Pfizer, Pune-based Serum Institute of India (SII), and Hyderabad-based Bharat Biotech have applied to the Drugs Controller General of India (DCGI) seeking emergency use authorisation (EUA) for their COVID-19 vaccines.
Meanwhile, Subject Expert Committee (SEC) of Drugs Controller General of India (DCGI) has asked for more safety and efficacy data from Serum Institute of India (SII) and Bharat Biotech for their COVID-19 vaccines.
Bharat Biotech Adds Top Medical Body ICMR As Co-Owner Of Covid Vaccine Patent "Remarkable Influence": Bharat Biotech Co-Founder Honoured By Johns Hopkins Top Medical Body Slams Study On Covaxin Safety, Side-Effects, Wants Apology At Olympics Opening Ceremony, Drag Parody Of 'The Last Supper' Draws Flak Centre Fact-Checks Mamata Banerjee's Mic-Off Claim, She Hits Back Children Of Indian-Americans Face Deportation As Time Runs Out Trump Vows To Hold Rallies With More Security Despite Assassination Attempt Fake Billing Scam Worth Thousands Of Crores Unearthed: Punjab Minister 'What Kind Of Democracy?' Court Raps Cops For Seeking Action On Professor Track Latest News Live on NDTV.com and get news updates from India and around the world.